GlassScriptPhysician profile
Charles D Cohn
NPI 1003044058
$4,959.69
in general payments reported to CMS, 2019-2025
15 companies · $734 in 2025
The $734 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $51.56 · 2020: $210 · 2021: $573 · 2022: $742 · 2023: $2,018 · 2024: $632 · 2025: $734.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Charitable Contribution: $1,700 · Food and Beverage: $1,684.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Charitable Contribution | $1,700.04 |
| Food and Beverage | $1,683.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Microsurgical Technology, INC. | $1,700.04 | 2023 | |
| Johnson & Johnson Surgical Vision, INC. | $1,449.30 | 2019-2025 | Veritas Vision System, Tecnis Iol, One Series Ultra |
| Rxsight INC | $934.96 | 2021-2025 | Rxsight Injector Handpiece, Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Alcon Vision LLC | $268.08 | 2022-2024 | Clareon, Centurion, Rocklatan |
| Abbvie INC. | $146.34 | 2022-2025 | Durysta |
| Depuy Synthes Sales INC. | $138.24 | 2023-2025 | Fms Duo, Attune |
| Tarsus Pharmaceuticals, INC. | $64.97 | 2024-2025 | Xdemvy |
| Bausch & Lomb Americas INC. | $63.35 | 2022-2024 | Vyzulta |
| Lensar, INC. | $54.01 | 2024 | Lensar Laser System |
| Allergan, INC. | $38.04 | 2021-2022 | |
| Merz Pharmaceuticals, LLC | $33.29 | 2022 | |
| Thea Pharma INC. | $22.73 | 2025 | Iyuzeh |
| Aerie Pharmaceuticals, INC. | $16.66 | 2021 | |
| Glaukos Corporation | $16.23 | 2025 | Istent Infinite, Idosetr |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $13.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Cohn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.